Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1957 of 5804
-
Short exercise program may cut heart risk in arthritis patients
Disease control CompletedThe aim of this study is to investigate the beneficial impacts of the 6-week standardized CR program applied to hypertensive RA patients whose disease activity is under control with regular pharmacological treatment. Subjects will be randomly assigned to one of two groups: 1.) s…
Phase: NA • Sponsor: Kayseri City Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
VR games may beat eye patches for lazy eye treatment
Disease control CompletedThe goal of this clinical trial is to evaluate the efficacy and safety of visual function training software (model: SJ-JRS2021) in the treatment of mild to moderate amblyopia in children. The main questions it aims to answer are: * Whether virtual reality training is more effect…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Sniffing out COVID: new At-Home smell test could spot infections early
Diagnosis OngoingThe purpose of this study is to learn more about how to better track smell recovery in people who have been infected with the SARS-CoV-2 virus (which causes COVID-19). Many people who have been infected by this virus develop changes in their sense of smell (olfaction). We are int…
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New Antibody-Drug combo targets Hard-to-Treat digestive cancers
Disease control CompletedA multi-center, open-label, study designed to evaluate the preliminary efficacy, safety and pharmacokinetics of RC108 in patients with c-Me-positive advanced digestive system malignancies.
Phase: PHASE2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could a diabetes drug help kids with rare PMM2-CDG?
Disease control TerminatedThis is a prospective, single-center, randomized, double-blind, placebo-controlled study designed to assess the safety, tolerability, and clinical and metabolic improvement of pediatric subjects with PMM2-CDG on oral epalrestat therapy vs. placebo.
Phase: PHASE3 • Sponsor: Maggie's Pearl, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Egg-Free flu vaccine tested in kids: could it be just as good?
Prevention TerminatedThe purpose of this study was to demonstrate the non-inferior HAI immune response of quadrivalent recombinant influenza vaccine (RIV4) vs licensed Egg-Based Quadrivalent Influenza Vaccine (IIV4) for the 4 strains based on the egg-derived antigen in all participants aged 3 to 8 ye…
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 26, 2026 14:42 UTC
-
Brazil launches massive cancer Gene-Mapping project in public hospitals
Knowledge-focused Recruiting nowThis project aims to perform complete sequencing of the somatic (tumor) and germline exomes during clinical investigation of cancer patients treated through the Brazilian Unified Health System to generate genomic and phenotypic data for the Brazilian Ministry of Health's National…
Sponsor: Hospital Moinhos de Vento • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New pill shows promise for severe baldness, but trial cut short
Disease control TerminatedThe purpose of this study is to assess KL130008 is safe and effective in adults with severe alopecia areata
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New sleep program aims to help Alzheimer's patients and caregivers rest better
Symptom relief Recruiting nowThis is a randomized controlled trial over 5 years, using Stage II of the NIH-defined stage model for behavioral intervention development. We will evaluate the efficacy of the sleep intervention program (Care2Sleep) on sleep, health status measures, and quality of life (for dyads…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Blood cancer patients get continued access to promising drug in new study
Disease control Recruiting nowThis extension study is designed to enroll participants with hematologic malignancies who are receiving clinical benefit from tafasitamab treatment in a parent study with tafasitamab..
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New COVID booster vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis was an exploratory Phase I, randomized, observer-blind, active-controlled, dose-escalation trial to evaluate four dose levels (DLs) of BNT162b4 given in combination with BNT162b2 Bivalent (original/Omicron BA.4/BA.5) to select a safe and tolerable dose and to evaluate BNT162…
Phase: PHASE1 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:10 UTC
-
Can a cuff that restricts blood flow speed up ACL recovery?
Disease control OngoingThe aim of this study is to investigate the efficacy of blood flow restriction (BFR) therapy in post-operative rehabilitation following knee arthroscopy for primary ACL reconstruction. BFR has been shown to effect time to return to activity and strength postoperatively. This stud…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can an IUD work as emergency contraception? large study aims to find out
Disease control Recruiting nowThis is a prospective clinical research study to test the effectiveness of the Levonorgestrel (LNG) 52 mg Intrauterine Device (IUD) for emergency contraception (EC) and same-day start use that will enroll people receiving care at Planned Parenthood affiliates across the U.S. Our …
Phase: PHASE4 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo therapy aims to lift mood after heart surgery in seniors
Symptom relief CompletedThis Hybrid 1 Study will test the effectiveness of a bundled intervention comprised of behavioral activation and medication optimization in reducing symptoms of depression and anxiety in older adults undergoing cardiac surgery (compared with usual care), while examining implement…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Boosted flu shot tested in hospital workers – could it offer better protection?
⭐️ VACCINE ⭐️ CompletedThis randomized, double-blinded trial will assess humoral immune responses to adjuvanted, egg-based quadrivalent influenza vaccines compared to standard dose, egg-based quadrivalent influenza vaccines among healthcare personnel (HCP). The trial will be conducted at two sites in L…
Phase: PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:35 UTC
-
New cancer drug BAY2965501 enters first human tests
Disease control OngoingResearchers are looking for a better way to treat people who have advanced solid tumors. Advanced solid tumors are types of cancer that may have spread to nearby tissue, lymph nodes, and/or to distant parts of the body and that are unlikely to be cured or controlled with currentl…
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental drug HZN-825 tested for rare autoimmune lung complication
Disease control TerminatedPrimary Objectives: 1. The primary efficacy objective is to assess the efficacy of 52 weeks of open-label treatment with HZN-825 in participants with diffuse cutaneous systemic sclerosis, as measured by change from both baselines in forced vital capacity percent (FVC %) predicte…
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a Head-Zap device lift depression without drugs?
Symptom relief CompletedPurpose of research: It aims to demonstrate the effectiveness of transcranial direct current stimulation (tDCS) in the clinical domain for patients with depression and to optimize home-based e-medication technology.
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Jun 26, 2026 16:19 UTC
-
Community-Led recovery: could indigenous wisdom curb substance use?
Disease control CompletedThis research project uses a Community-Based Participatory Research (CBPR) framework to test the efficacy of a culturally adapted relapse prevention intervention developed collaboratively by community partners from the Fort Peck Indian Reservation in northeastern Montana and rese…
Phase: NA • Sponsor: Montana State University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New wearable device could uncover hidden stroke cause
Diagnosis CompletedThe aim of the study is to evaluate the efficacy and safety of the Cardea SOLO Compared to 12 lead EKG for Paroxysmal Atrial Fibrillation Diagnosis in ESUS patients with Left Atrial Enlargement.
Phase: NA • Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC